Igor Morozov, DVM, PhD, has directed research in veterinary virology and animal health for more than two decades. He has been CEEZAD’s science project manager since the Center’s creation in 2010. His research focuses on emerging and zoonotic viral diseases and vaccine development for companion and agricultural species. He has conducted research on molecular virology of viral infections of swine, specifically PRRSV and PCV2, and managed multiple projects on the development of veterinary vaccines. Currently, his research is focused on vaccine and diagnostics for high-threat select agent pathogens, such as RVFV, ASF, and FMD. Beyond his coordination of CEEZAD research projects, he contributes to the preparation of multiple project plans, reports, and research grant proposals. Dr. Morozov is a graduate of the Moscow Veterinary Academy, where he received his DVM in 1985, and of the Institute Of Experimental Veterinary Medicine, where he earned his PhD in virology and molecular biology in 1991. He has since worked in numerous capacities both in Russia and the United States, including as a senior scientist at the Laboratory of Molecular Biology and Biochemistry in Moscow, a postdoctoral research associate at the Veterinary Medical Research Unit at Iowa State University, and a principal lead scientist and project leader at Fort Dodge Animal Health in Iowa. Prior to joining the staff at CEEZAD, he was most recently a research and development supervisor and project leader at Novartis Animal Health. He is the principal investigator for the development of vaccines and diagnostics for Epizootic Hemorrhagic Disease Virus and contributes to multiple CEEZAD projects involving the development of vaccines and diagnostics for high-threat and emerging zoonotic pathogens. The author of more than a dozen peer-reviewed articles on various aspects of veterinary microbiology, he is a member of the United States Animal Health Association and the Society of Phi Zeta, Honor Society of Veterinary Medicine [citation].